A technology-enabled service to optimise insulin management

Summary

The d-Nav Insulin Guidance Service is a technology-enabled managed service providing automated insulin dosage titration for patients using basal, premixed, and basal-bolus insulin regimens with and without carb counting. When implemented in a Trust in Northern Ireland mean HbA1c decreased and patient satisfaction was high. Meanwhile, cost effectiveness analysis demonstrates that d-Nav is cheaper than the current standard of care.

Challenge

Achieving good glycaemic control in type 2 Diabetes is important to prevent mortality and costly complications. Unfortunately achieving good glycaemic control in people with type 2 Diabetes is a worldwide challenge. Standard UK clinical practice is to start with dietary and lifestyle modification, progressing to antidiabetic drug therapy when glycaemic control is no longer achieved and intensifying drug therapy if the patient remains above target. Yet even when using insulin many patients still fail to achieve glycaemic control targets - many patients are only seen for dosage adjustment every six months.

Objectives

To improve glycaemic control using the technology-enabled d-Nav insulin guidance service for patients with type 2 diabetes using insulin in South Eastern HSC Trust. To show that d-Nav is more cost effective than the current standard of care, making better use of insulin and reducing use of concomitant medications.

Back to the top

  • KEY DATES
  • Closed for entry
  • Nomination deadline:
    Friday 28 July
  • Judging day: Tuesday 18 July
  • Finalists notification: Tuesday 1 August – Friday 4 August
  • Awards presentation:
    Thursday 12 October at Sanofi UK & Ireland headquarters in Guildford, Surrey
QiC Diabetes is partnered by:
Supported by: